148 related articles for article (PubMed ID: 31566616)
1. An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis.
Qi X; Schepers E; Avella D; Kimchi ET; Kaifi JT; Staveley-O'Carroll KF; Li G
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566616
[TBL] [Abstract][Full Text] [Related]
2. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
3. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
4. Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.
Li G; Liu D; Cooper TK; Kimchi ET; Qi X; Avella DM; Li N; Yang QX; Kester M; Rountree CB; Kaifi JT; Cole DJ; Rockey DC; Schell TD; Staveley-O'Carroll KF
J Hepatol; 2017 Jan; 66(1):75-85. PubMed ID: 27520877
[TBL] [Abstract][Full Text] [Related]
5. Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.
Avella DM; Li G; Schell TD; Liu D; Zhang SS; Lou X; Berg A; Kimchi ET; Tagaram HR; Yang Q; Shereef S; Garcia LS; Kester M; Isom HC; Rountree CB; Staveley-O'Carroll KF
Hepatology; 2012 Jan; 55(1):141-52. PubMed ID: 21898502
[TBL] [Abstract][Full Text] [Related]
6. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
[TBL] [Abstract][Full Text] [Related]
7. Two-stage model of chemically induced hepatocellular carcinoma in mouse.
Luo M; Yang F; Huang SX; Kuang ZP; Luo XL; Li YD; Wu JN; Xie YA
Oncol Res; 2013; 20(11):517-28. PubMed ID: 24063282
[TBL] [Abstract][Full Text] [Related]
8. An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.
Reiberger T; Chen Y; Ramjiawan RR; Hato T; Fan C; Samuel R; Roberge S; Huang P; Lauwers GY; Zhu AX; Bardeesy N; Jain RK; Duda DG
Nat Protoc; 2015 Aug; 10(8):1264-74. PubMed ID: 26203823
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
Kaffe E; Katsifa A; Xylourgidis N; Ninou I; Zannikou M; Harokopos V; Foka P; Dimitriadis A; Evangelou K; Moulas AN; Georgopoulou U; Gorgoulis VG; Dalekos GN; Aidinis V
Hepatology; 2017 Apr; 65(4):1369-1383. PubMed ID: 27981605
[TBL] [Abstract][Full Text] [Related]
10. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
[TBL] [Abstract][Full Text] [Related]
11. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
12. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma.
Li H
Dig Liver Dis; 2022 May; 54(5):598-613. PubMed ID: 34344577
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
14. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
15. Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model.
Li Y; Agrawal I; Gong Z
Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31515263
[TBL] [Abstract][Full Text] [Related]
16. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
18. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
19. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
[TBL] [Abstract][Full Text] [Related]
20. AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
Fang CC; Wu CF; Liao YJ; Huang SF; Chen M; Chen YA
Sci Rep; 2018 Sep; 8(1):13802. PubMed ID: 30217986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
